Skip to main content
Top
Published in: Journal of Medical Case Reports 1/2018

Open Access 01-12-2018 | Case report

Novel in-frame deletion in MFSD8 gene revealed by trio whole exome sequencing in an Iranian affected with neuronal ceroid lipofuscinosis type 7: a case report

Authors: Ali Hosseini Bereshneh, Masoud Garshasbi

Published in: Journal of Medical Case Reports | Issue 1/2018

Login to get access

Abstract

Background

The neuronal ceroid lipofuscinoses are a group of neurodegenerative, lysosomal storage disorders. They are inherited as an autosomal recessive pattern with the exception of adult neuronal ceroid lipofuscinosis, which can be inherited in either an autosomal recessive or an autosomal dominant manner. The neuronal ceroid lipofuscinoses are characterized by accumulation of autofluorescent lipopigments in the cells and one of the most important pathological manifestations is ceroid accumulation in the lysosomes. Various types of neuronal ceroid lipofuscinoses are categorized based on the clinical manifestations and the genes involved. Accumulatively, 15 different genes have been found so far to be implicated in the pathogenesis of at least nine different types of neuronal ceroid lipofuscinoses, which result in similar pathological and clinical manifestations.

Case presentation

A 5-year-old Iranian boy affected by a neurodegenerative disorder with speech problems, lack of concentration, walking disability at age of 4 years leading to quadriplegia, spontaneous laughing, hidden seizure, clumsiness, psychomotor delay, and vision deterioration at age of 5 years, which could be the consequence of macular dystrophy, was referred to us for genetic testing. Trio whole exome sequencing, Sanger validation, and segregation analysis discovered a novel in-frame small deletion c.325_339del (p.Val109_Ile113del) in MFSD8 gene associated with neuronal ceroid lipofuscinosis type 7.

Conclusions

The deletion found in this patient affects the exon 5 of this gene which is the region encoding transmembrane domain. Sequencing analysis in this family has shown that the index is homozygous for 15 base pairs in-frame deletion, his uncle has normal homozygous, and his parents are heterozygous. This pattern of mutation inheritance and the signs and symptoms observed in the affected male of this family are compatible with what is described in the literature for neuronal ceroid lipofuscinosis type 7 and, therefore, suggest that the MFSD8 gene deletion found in this study is most probably the cause of disease in this family.
Literature
1.
go back to reference Geraets RD, Koh SY, Hastings ML, Kielian T, Pearce DA, Weimer JM. Moving towards effective therapeutic strategies for Neuronal Ceroid Lipofuscinosis. Orphanet J. Rare Dis. 2016;11(1):40. Geraets RD, Koh SY, Hastings ML, Kielian T, Pearce DA, Weimer JM. Moving towards effective therapeutic strategies for Neuronal Ceroid Lipofuscinosis. Orphanet J. Rare Dis. 2016;11(1):40.
2.
go back to reference Bennett MJ, Rakheja D. The neuronal ceroid-lipofuscinoses. Dev. Disabil. Res. Rev. 2013;17(3):254–9.CrossRef Bennett MJ, Rakheja D. The neuronal ceroid-lipofuscinoses. Dev. Disabil. Res. Rev. 2013;17(3):254–9.CrossRef
3.
go back to reference Jadav RH, Sinha S, Yasha TC, Aravinda H, Gayathri N, Rao S, Bindu PS, Satishchandra P. Clinical, electrophysiological, imaging, and ultrastructural description in 68 patients with neuronal ceroid lipofuscinoses and its subtypes. Pediatr Neurol. 2014;50(1):85–95.CrossRef Jadav RH, Sinha S, Yasha TC, Aravinda H, Gayathri N, Rao S, Bindu PS, Satishchandra P. Clinical, electrophysiological, imaging, and ultrastructural description in 68 patients with neuronal ceroid lipofuscinoses and its subtypes. Pediatr Neurol. 2014;50(1):85–95.CrossRef
4.
go back to reference Albert D, De Los RE, Vidaurre J. A case of neuronal Ceroid Lipofuscinosis masquerading as Panayiotopoulos syndrome. J Pediatr Epilepsy. 2016;5(01):047–52. Albert D, De Los RE, Vidaurre J. A case of neuronal Ceroid Lipofuscinosis masquerading as Panayiotopoulos syndrome. J Pediatr Epilepsy. 2016;5(01):047–52.
5.
go back to reference Stogmann E, El Tawil S, Wagenstaller J, Gaber A, Edris S, Abdelhady A, Assem-Hilger E, Leutmezer F, Bonelli S, Baumgartner C, Zimprich F. A novel mutation in the MFSD8 gene in late infantile neuronal ceroid lipofuscinosis. Neurogenetics. 2009;10(1):73–7.CrossRef Stogmann E, El Tawil S, Wagenstaller J, Gaber A, Edris S, Abdelhady A, Assem-Hilger E, Leutmezer F, Bonelli S, Baumgartner C, Zimprich F. A novel mutation in the MFSD8 gene in late infantile neuronal ceroid lipofuscinosis. Neurogenetics. 2009;10(1):73–7.CrossRef
6.
go back to reference Mink JW, Augustine EF, Adams HR, Marshall FJ, Kwon JM. Classification and natural history of the neuronal ceroid lipofuscinoses. J Child Neurol. 2013;9:0883073813494268. Mink JW, Augustine EF, Adams HR, Marshall FJ, Kwon JM. Classification and natural history of the neuronal ceroid lipofuscinoses. J Child Neurol. 2013;9:0883073813494268.
7.
go back to reference Haltia M, Goebel HH. The neuronal ceroid-lipofuscinoses: a historical introduction. Biochim Biophys Acta. 2013;1832(11):1795–800.CrossRef Haltia M, Goebel HH. The neuronal ceroid-lipofuscinoses: a historical introduction. Biochim Biophys Acta. 2013;1832(11):1795–800.CrossRef
8.
go back to reference Goebel HH, Mole SE, Lake BD. The neuronal ceroid lipofuscinoses (Batten disease). Amsterdam: IOS Press; 1999. Goebel HH, Mole SE, Lake BD. The neuronal ceroid lipofuscinoses (Batten disease). Amsterdam: IOS Press; 1999.
10.
go back to reference Warrier V, Vieira M, Mole SE. Genetic basis and phenotypic correlations of the neuronal ceroid lipofuscinoses. Biochim Biophys Acta. 2013;1832(11):1827–30.CrossRef Warrier V, Vieira M, Mole SE. Genetic basis and phenotypic correlations of the neuronal ceroid lipofuscinoses. Biochim Biophys Acta. 2013;1832(11):1827–30.CrossRef
11.
go back to reference Sleat DE, Gin RM, Sohar I, Wisniewski K, Sklower-Brooks S, Pullarkat RK, Palmer DN, Lerner TJ, Boustany RM, Uldall P, Siakotos AN. Mutational analysis of the defective protease in classic late-infantile neuronal ceroid lipofuscinosis, a neurodegenerative lysosomal storage disorder. Am J Hum Genet. 1999;64(6):1511–23.CrossRef Sleat DE, Gin RM, Sohar I, Wisniewski K, Sklower-Brooks S, Pullarkat RK, Palmer DN, Lerner TJ, Boustany RM, Uldall P, Siakotos AN. Mutational analysis of the defective protease in classic late-infantile neuronal ceroid lipofuscinosis, a neurodegenerative lysosomal storage disorder. Am J Hum Genet. 1999;64(6):1511–23.CrossRef
12.
go back to reference Mole SE, Williams RE, Goebel HH. Correlations between genotype, ultrastructural morphology and clinical phenotype in the neuronal ceroid lipofuscinoses. Neurogenetics. 2005;6(3):107–26.CrossRef Mole SE, Williams RE, Goebel HH. Correlations between genotype, ultrastructural morphology and clinical phenotype in the neuronal ceroid lipofuscinoses. Neurogenetics. 2005;6(3):107–26.CrossRef
13.
go back to reference Jalanko A, Braulke T. Neuronal ceroid lipofuscinoses. Biochim Biophys Acta. 2009;1793(4):697–709.CrossRef Jalanko A, Braulke T. Neuronal ceroid lipofuscinoses. Biochim Biophys Acta. 2009;1793(4):697–709.CrossRef
14.
go back to reference Sleat DE, Donnelly RJ, Lackland H, Liu CG, Sohar I, Pullarkat RK, Lobel P. Association of mutations in a lysosomal protein with classical late-infantile neuronal ceroid lipofuscinosis. Science. 1997;277(5333):1802–5.CrossRef Sleat DE, Donnelly RJ, Lackland H, Liu CG, Sohar I, Pullarkat RK, Lobel P. Association of mutations in a lysosomal protein with classical late-infantile neuronal ceroid lipofuscinosis. Science. 1997;277(5333):1802–5.CrossRef
15.
go back to reference Nita DA, Mole SE, Minassian BA. Neuronal ceroid lipofuscinoses. Epileptic Disord. 2016;18(s2):73–88.PubMed Nita DA, Mole SE, Minassian BA. Neuronal ceroid lipofuscinoses. Epileptic Disord. 2016;18(s2):73–88.PubMed
16.
go back to reference Götzl JK, Mori K, Damme M, Fellerer K, Tahirovic S, Kleinberger G, Janssens J, van der Zee J, Lang CM, Kremmer E, Martin JJ. Common pathobiochemical hallmarks of progranulin-associated frontotemporal lobar degeneration and neuronal ceroid lipofuscinosis. Acta Neuropathol. 2014;127(6):845–60.PubMed Götzl JK, Mori K, Damme M, Fellerer K, Tahirovic S, Kleinberger G, Janssens J, van der Zee J, Lang CM, Kremmer E, Martin JJ. Common pathobiochemical hallmarks of progranulin-associated frontotemporal lobar degeneration and neuronal ceroid lipofuscinosis. Acta Neuropathol. 2014;127(6):845–60.PubMed
17.
go back to reference Karaa A, Simas AM, John S, Glykys J, Xin W, Cotman SL, Sims KB. Expanding the clinical spectrum of the lysosomal disorders with whole exome sequencing. Abstracts/Mol. Genet. Metab. 2015;114:S11–30. Karaa A, Simas AM, John S, Glykys J, Xin W, Cotman SL, Sims KB. Expanding the clinical spectrum of the lysosomal disorders with whole exome sequencing. Abstracts/Mol. Genet. Metab. 2015;114:S11–30.
18.
go back to reference Patel J, Mercimek-Mahmutoglu S. Epileptic encephalopathy in childhood: a stepwise approach for identification of underlying genetic causes. Indian J. Pediatr. 2016;83(10):1164–74.CrossRef Patel J, Mercimek-Mahmutoglu S. Epileptic encephalopathy in childhood: a stepwise approach for identification of underlying genetic causes. Indian J. Pediatr. 2016;83(10):1164–74.CrossRef
19.
go back to reference García-Cazorla A, Wolf NI, Mochel F, Hoffmann GF. Neurological disease. In: Hoffman GF, Zschocke J, Nyhan WL, editors. Inherited metabolic diseases: A clinical approach. Berlin Heidelberg: Springer; 2017. p. 251–92.CrossRef García-Cazorla A, Wolf NI, Mochel F, Hoffmann GF. Neurological disease. In: Hoffman GF, Zschocke J, Nyhan WL, editors. Inherited metabolic diseases: A clinical approach. Berlin Heidelberg: Springer; 2017. p. 251–92.CrossRef
20.
go back to reference Langereis EJ, Wijburg FA. Lysosomal diseases and therapeutic options: an overview. In: Boelens JJ, Wynn R, editors. Stem cell therapy in Lysosomal storage diseases. New York: Springer; 2013. p. 1–20. Langereis EJ, Wijburg FA. Lysosomal diseases and therapeutic options: an overview. In: Boelens JJ, Wynn R, editors. Stem cell therapy in Lysosomal storage diseases. New York: Springer; 2013. p. 1–20.
21.
go back to reference Cooper JD, Williams RE. Neuronal Ceroid Lipofuscinoses. In: Mehta A, Winchester B, editors. Lysosomal Storage Disorders: A Practical Guide, vol. 4; 2012. p. 137–41.CrossRef Cooper JD, Williams RE. Neuronal Ceroid Lipofuscinoses. In: Mehta A, Winchester B, editors. Lysosomal Storage Disorders: A Practical Guide, vol. 4; 2012. p. 137–41.CrossRef
22.
go back to reference Järvelä I, Schleutker J, Haataja L, Santavuori P, Puhakka L, Manninen T, Palotie A, Sandkuijl LA, Renlund M, White R, Aula P. Infantile form of neuronal ceroid lipofuscinosis (CLN1) maps to the short arm of chromosome 1. Genomics. 1991;9(1):170–3.CrossRef Järvelä I, Schleutker J, Haataja L, Santavuori P, Puhakka L, Manninen T, Palotie A, Sandkuijl LA, Renlund M, White R, Aula P. Infantile form of neuronal ceroid lipofuscinosis (CLN1) maps to the short arm of chromosome 1. Genomics. 1991;9(1):170–3.CrossRef
23.
go back to reference Grisolia M, Sestito S, Ceravolo F, Invernizzi F, Salpietro V, Polizzi A, Ruggieri M, Garavaglia B, Concolino D. The neuronal Ceroid Lipofuscinoses: a case-based overview. J Pediatr Biochemistry. 2016;6(01):060–5.CrossRef Grisolia M, Sestito S, Ceravolo F, Invernizzi F, Salpietro V, Polizzi A, Ruggieri M, Garavaglia B, Concolino D. The neuronal Ceroid Lipofuscinoses: a case-based overview. J Pediatr Biochemistry. 2016;6(01):060–5.CrossRef
24.
go back to reference Mahmood F, Fu S, Cooke J, Wilson SW, Cooper JD, Russell C. A zebrafish model of CLN2 disease is deficient in tripeptidyl peptidase 1 and displays progressive neurodegeneration accompanied by a reduction in proliferation. Brain. 2013;136:1488–507.CrossRef Mahmood F, Fu S, Cooke J, Wilson SW, Cooper JD, Russell C. A zebrafish model of CLN2 disease is deficient in tripeptidyl peptidase 1 and displays progressive neurodegeneration accompanied by a reduction in proliferation. Brain. 2013;136:1488–507.CrossRef
25.
go back to reference Minye HM, Fabritius AL, Vesa J, Peltonen L. Data on characterizing the gene expression patterns of neuronal ceroid lipofuscinosis genes: CLN1, CLN2, CLN3, CLN5 and their association to interneuron and neurotransmission markers: Parvalbumin and Somatostatin. Data in Brief. 2016;8:741–9.CrossRef Minye HM, Fabritius AL, Vesa J, Peltonen L. Data on characterizing the gene expression patterns of neuronal ceroid lipofuscinosis genes: CLN1, CLN2, CLN3, CLN5 and their association to interneuron and neurotransmission markers: Parvalbumin and Somatostatin. Data in Brief. 2016;8:741–9.CrossRef
26.
go back to reference Mole SE, Goyal S, Williams RE. The neuronal Ceroid Lipofuscinoses. In: Panayiotopoulos CP, editor. Atlas of epilepsies. London: Springer; 2010. p. 1235–41.CrossRef Mole SE, Goyal S, Williams RE. The neuronal Ceroid Lipofuscinoses. In: Panayiotopoulos CP, editor. Atlas of epilepsies. London: Springer; 2010. p. 1235–41.CrossRef
27.
go back to reference Kashyap SS, Johnson JR, McCue HV, Chen X, Edmonds MJ, Ayala M, Graham ME, Jenn RC, Barclay JW, Burgoyne RD, Morgan A. Caenorhabditis elegans dnj-14, the orthologue of the DNAJC5 gene mutated in adult onset neuronal ceroid lipofuscinosis, provides a new platform for neuroprotective drug screening and identifies a SIR-2.1-independent action of resveratrol. Human Molecular Genetics. 2014;23:5916–27.CrossRef Kashyap SS, Johnson JR, McCue HV, Chen X, Edmonds MJ, Ayala M, Graham ME, Jenn RC, Barclay JW, Burgoyne RD, Morgan A. Caenorhabditis elegans dnj-14, the orthologue of the DNAJC5 gene mutated in adult onset neuronal ceroid lipofuscinosis, provides a new platform for neuroprotective drug screening and identifies a SIR-2.1-independent action of resveratrol. Human Molecular Genetics. 2014;23:5916–27.CrossRef
28.
go back to reference Craiu D, Dragostin O, Dica A, Hoffman-Zacharska D, Gos M, Bastian AE, Gherghiceanu M, Rolfs A, Nahavandi N, Craiu M, Iliescu C. Rett-like onset in late-infantile neuronal ceroid lipofuscinosis (CLN7) caused by compound heterozygous mutation in the MFSD8 gene and review of the literature data on clinical onset signs. Eur J Paediatr Neurol. 2015;19(1):78–86.CrossRef Craiu D, Dragostin O, Dica A, Hoffman-Zacharska D, Gos M, Bastian AE, Gherghiceanu M, Rolfs A, Nahavandi N, Craiu M, Iliescu C. Rett-like onset in late-infantile neuronal ceroid lipofuscinosis (CLN7) caused by compound heterozygous mutation in the MFSD8 gene and review of the literature data on clinical onset signs. Eur J Paediatr Neurol. 2015;19(1):78–86.CrossRef
29.
go back to reference Ashkenazy H, Erez E, Martz E, Pupko T, Ben-Tal N. ConSurf 2010: calculating evolutionary conservation in sequence and structure of proteins and nucleic acids. Nucleic Acids Res. 2010;38:W529–33.CrossRef Ashkenazy H, Erez E, Martz E, Pupko T, Ben-Tal N. ConSurf 2010: calculating evolutionary conservation in sequence and structure of proteins and nucleic acids. Nucleic Acids Res. 2010;38:W529–33.CrossRef
30.
go back to reference Aiello C, Terracciano A, Simonati A, Discepoli G, Cannelli N, Claps D, Crow YJ, Bianchi M, Kitzmuller C, Longo D, Tavoni A. Mutations in MFSD8/CLN7 are a frequent cause of variant-late infantile neuronal ceroid lipofuscinosis. Hum Mutat. 2009;30(3):E530–40.CrossRef Aiello C, Terracciano A, Simonati A, Discepoli G, Cannelli N, Claps D, Crow YJ, Bianchi M, Kitzmuller C, Longo D, Tavoni A. Mutations in MFSD8/CLN7 are a frequent cause of variant-late infantile neuronal ceroid lipofuscinosis. Hum Mutat. 2009;30(3):E530–40.CrossRef
31.
go back to reference Abrams MT, Doheny KF, Mazzocco MM, Knight SJ, Baumgardner TL, Freund LS, Davies KE, Reiss AL. Cognitive, behavioral, and neuroanatomical assessment of two unrelated male children expressing FRAXE. Am J Med Genet. 1997;74(1):73–81.CrossRef Abrams MT, Doheny KF, Mazzocco MM, Knight SJ, Baumgardner TL, Freund LS, Davies KE, Reiss AL. Cognitive, behavioral, and neuroanatomical assessment of two unrelated male children expressing FRAXE. Am J Med Genet. 1997;74(1):73–81.CrossRef
32.
go back to reference Bensaid M, Melko M, Bechara EG, Davidovic L, Berretta A, Catania MV, Gecz J, Lalli E, Bardoni B. FRAXE-associated mental retardation protein (FMR2) is an RNA-binding protein with high affinity for G-quartet RNA forming structure. Nucleic Acids Research. 2009;37:1269–79.CrossRef Bensaid M, Melko M, Bechara EG, Davidovic L, Berretta A, Catania MV, Gecz J, Lalli E, Bardoni B. FRAXE-associated mental retardation protein (FMR2) is an RNA-binding protein with high affinity for G-quartet RNA forming structure. Nucleic Acids Research. 2009;37:1269–79.CrossRef
33.
go back to reference Mondal K, Ramachandran D, Patel VC, Hagen KR, Bose P, Cutler DJ, Zwick ME. Excess variants in AFF2 detected by massively parallel sequencing of males with autism spectrum disorder. Hum Mol Genet. 2012;21(19):4356–64.CrossRef Mondal K, Ramachandran D, Patel VC, Hagen KR, Bose P, Cutler DJ, Zwick ME. Excess variants in AFF2 detected by massively parallel sequencing of males with autism spectrum disorder. Hum Mol Genet. 2012;21(19):4356–64.CrossRef
34.
go back to reference Weinstein E, Cui X, Simmons P, Sigma-Aldrich Co. Genomic editing of genes involved in autism spectrum disorders. United States patent application US 12/842,678. 2010. Weinstein E, Cui X, Simmons P, Sigma-Aldrich Co. Genomic editing of genes involved in autism spectrum disorders. United States patent application US 12/842,678. 2010.
35.
go back to reference Todorova A, Litvinenko I, Todorov T, Tincheva R, Avdjieva D, Tincheva S, Mitev V. A family with fragile X syndrome, Duchenne muscular dystrophy and ichthyosis transmitted by an asymptomatic carrier. Clin Genet. 2014;85(3):286–9.CrossRef Todorova A, Litvinenko I, Todorov T, Tincheva R, Avdjieva D, Tincheva S, Mitev V. A family with fragile X syndrome, Duchenne muscular dystrophy and ichthyosis transmitted by an asymptomatic carrier. Clin Genet. 2014;85(3):286–9.CrossRef
36.
go back to reference Sahoo T, Theisen A, Marble M, Tervo R, Rosenfeld JA, Torchia BS, Shaffer LG. Microdeletion of Xq28 involving the AFF2 (FMR2) gene in two unrelated males with developmental delay. Am J Med Genet A. 2011;155(12):3110–5.CrossRef Sahoo T, Theisen A, Marble M, Tervo R, Rosenfeld JA, Torchia BS, Shaffer LG. Microdeletion of Xq28 involving the AFF2 (FMR2) gene in two unrelated males with developmental delay. Am J Med Genet A. 2011;155(12):3110–5.CrossRef
37.
go back to reference Santos CB, Lima C, Pimentel MM. A new PCR assay useful for screening of FRAXE/FMR2 mental impairment among males. Hum Mutat. 2001;18(2):157–62.CrossRef Santos CB, Lima C, Pimentel MM. A new PCR assay useful for screening of FRAXE/FMR2 mental impairment among males. Hum Mutat. 2001;18(2):157–62.CrossRef
Metadata
Title
Novel in-frame deletion in MFSD8 gene revealed by trio whole exome sequencing in an Iranian affected with neuronal ceroid lipofuscinosis type 7: a case report
Authors
Ali Hosseini Bereshneh
Masoud Garshasbi
Publication date
01-12-2018
Publisher
BioMed Central
Published in
Journal of Medical Case Reports / Issue 1/2018
Electronic ISSN: 1752-1947
DOI
https://doi.org/10.1186/s13256-018-1788-7

Other articles of this Issue 1/2018

Journal of Medical Case Reports 1/2018 Go to the issue